IDDF2018-ABS-0112 Safety and efficacy of sofosbuvir/velpatasvir in a genotype 1–6 hcv infected population from singapore, malaysia, thailand, and vietnam: results from a phase 3, c... von Lim, Seng Gee, Mohamed, Rosmawati, Le, Phuong, Tee, Hoi Poh, McNabb, Brian, Lu, Sofia, Lu, Julia, McNally, John, Brainard, Diana M, Mani Subramanian, G, Sze Man Yip, Christina, Huang, Hai Cheng, Tan, Chee Kiat, Tanwandee, Tawesak, Van, Kinh Nguyen, Piratvisuth, Teerha

Volltext

IDDF2018-ABS-0110 Efficacy and safety of SOFOSBUVIR/VELPATASVIR plus RIBAVIRIN for 12 or 24 weeks in genotype 1 or 2 HCV-INFECTED japanese patients with prior treatment failure to... von Izumi, Namiki, Takehara, Tetsuo, Chayama, Kazuaki, Yatsuhashi, Hiroshi, Takaguchi, Koichi, Ide, Tatsuya, Kurosaki, Masayuki, Ueno, Yoshiyuki, Toyoda, Hidenori, Kakizaki, Satoru, Tanaka, Yasuhito, Kawakami, Yoshiiku, Enomoto, Hirayuki, Ikeda, Fusao, Huang, KC, De-Oertel, Shampa, McNabb, Brian L, Camus, Gregory, McNally, John, Brainard, Diana M, Sze Man Yip, Christina, Huang, Hai Cheng, McHutchison, John G, Mochida, Satoshi, Mizokami, Masashi

Volltext